SOPHiA GENETICS Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine

04.1.2019 –  Sophia Genetics, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data-Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest Partners, a European leader in private equity, alongside existing investors including Balderton Capital and Alychlo.

Read the complete news on Sophia Genetics’ website